GB9929569D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number: GB9929569D0
Authority: GB; United Kingdom
Prior art keywords: therapeutic agents; therapeutic; agents
Prior art date: 1999-12-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB9929569.3A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Organon Pharma UK Ltd

Original Assignee

Merck Sharp and Dohme Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-14

Filing date

1999-12-14

Publication date

2000-02-09

1999-12-14 Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd

1999-12-14 Priority to GBGB9929569.3A priority Critical patent/GB9929569D0/en

2000-02-09 Publication of GB9929569D0 publication Critical patent/GB9929569D0/en

2000-12-11 Priority to JP2001544740A priority patent/JP2003516994A/en

2000-12-11 Priority to AU21954/01A priority patent/AU780554B2/en

2000-12-11 Priority to PCT/GB2000/004752 priority patent/WO2001044250A1/en

2000-12-11 Priority to CA002392955A priority patent/CA2392955A1/en

2000-12-11 Priority to EP00985541A priority patent/EP1242423A1/en

2000-12-11 Priority to US10/149,852 priority patent/US7144887B2/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Hospice & Palliative Care (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Psychiatry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

GBGB9929569.3A 1999-12-14 1999-12-14 Therapeutic agents Ceased GB9929569D0 (en)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
GBGB9929569.3A GB9929569D0 (en)	1999-12-14	1999-12-14	Therapeutic agents
JP2001544740A JP2003516994A (en)	1999-12-14	2000-12-11	Substituted 1,2,3-triazolo [1,5-a] quinazolines for improving cognitive ability
AU21954/01A AU780554B2 (en)	1999-12-14	2000-12-11	Substituted 1,2,3-triazolo(1,5-a)quinazolines for enhancing cognition
PCT/GB2000/004752 WO2001044250A1 (en)	1999-12-14	2000-12-11	SUBSTITUTED 1,2,3-TRIAZOLO[1,5-a]QUINAZOLINES FOR ENHANCING COGNITION
CA002392955A CA2392955A1 (en)	1999-12-14	2000-12-11	Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition
EP00985541A EP1242423A1 (en)	1999-12-14	2000-12-11	SUBSTITUTED 1,2,3-TRIAZOLO 1,5-a]QUINAZOLINES FOR ENHANCING COGNITION
US10/149,852 US7144887B2 (en)	1999-12-14	2000-12-11	Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9929569.3A GB9929569D0 (en)	1999-12-14	1999-12-14	Therapeutic agents

Publications (1)

Publication Number	Publication Date
GB9929569D0 true GB9929569D0 (en)	2000-02-09

Family

ID=10866311

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9929569.3A Ceased GB9929569D0 (en)	1999-12-14	1999-12-14	Therapeutic agents

Country Status (7)

Country	Link
US (1)	US7144887B2 (en)
EP (1)	EP1242423A1 (en)
JP (1)	JP2003516994A (en)
AU (1)	AU780554B2 (en)
CA (1)	CA2392955A1 (en)
GB (1)	GB9929569D0 (en)
WO (1)	WO2001044250A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0108475D0 (en) *	2001-04-04	2001-05-23	Merck Sharp & Dohme	New compounds
EP2321285A1 (en)	2008-07-28	2011-05-18	F. Hoffmann-La Roche AG	Diazepan and piperazine derivatives modulators of chemokine receptors
EP3034079B1 (en)	2010-11-15	2018-01-10	Agenebio, Inc.	Pyridazine derivatives, compositions and methods for treating cognitive impairment
CA2817988A1 (en) *	2010-11-15	2012-05-24	Agenebio, Inc.	Benzodiazepine derivatives, compositions and methods for treating cognitive impairment
US20150374705A1 (en)	2012-02-14	2015-12-31	Shanghai Institues for Biological Sciences	Substances for treatment or relief of pain
CA2869535A1 (en) *	2012-05-30	2013-12-05	F. Hoffmann-La Roche Ag	Pyrrolidino heterocycles
WO2015095783A1 (en)	2013-12-20	2015-06-25	Agenebio, Inc.	Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
WO2016205739A1 (en)	2015-06-19	2016-12-22	Belew Mekonnen	Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CN107344937A (en) *	2016-05-06	2017-11-14	如东赛默罗生物科技有限公司	Triazol [1,5-a] quinazoline derivative, its preparation method, pharmaceutical composition and purposes
US11505555B2 (en)	2016-12-19	2022-11-22	Agenebio, Inc.	Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
BR112020026062B1 (en)	2018-06-19	2023-04-04	Agenebio, Inc	COMPOUNDS DERIVATIVES OF BENZODIAZEPINE OR A PHARMACEUTICALLY ACCEPTABLE SALT, ISOMER OR COMBINATION THEREOF, PHARMACEUTICAL COMPOSITION COMPRISING THEM AND USES THEREOF FOR THE TREATMENT OF COGNITIVE IMPAIRMENT, BRAIN CANCER AND PSYCHOSIS OF PARKINSON'S DISEASE

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI81350C (en) *	1982-01-18	1990-10-10	Lepetit Spa	ANALOGFOERFARANDE FOER FRAMSTAELLNING AV NYA, FARMAKOLOGISKT AKTIVA 6-SUBSTITUERADE S-TRIATSOLO / 3,4-A / PTHALAZINDERIVAT.
US5306819A (en) *	1992-08-27	1994-04-26	Neurogen Corporation	Certain aryl a cycloalkyl fused imidazopyrazinols; and new class of GABA brain receptor ligands
DE19617862A1 (en) *	1996-04-23	1997-10-30	Schering Ag	New phenyl-azolo:phthalazine compounds
EP0915875B1 (en) *	1996-07-25	2003-04-09	MERCK SHARP & DOHME LTD.	Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
WO1998050385A1 (en) *	1997-05-08	1998-11-12	Merck Sharp & Dohme Limited	SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS
GB9813006D0 (en) *	1998-06-16	1998-08-12	Merck Sharp & Dohme	Therapeutic agents
GB9929687D0 (en) *	1999-12-15	2000-02-09	Merck Sharp & Dohme	Therapeutic agents

1999
- 1999-12-14 GB GBGB9929569.3A patent/GB9929569D0/en not_active Ceased
2000
- 2000-12-11 CA CA002392955A patent/CA2392955A1/en not_active Abandoned
- 2000-12-11 AU AU21954/01A patent/AU780554B2/en not_active Ceased
- 2000-12-11 US US10/149,852 patent/US7144887B2/en not_active Expired - Fee Related
- 2000-12-11 EP EP00985541A patent/EP1242423A1/en not_active Withdrawn
- 2000-12-11 JP JP2001544740A patent/JP2003516994A/en not_active Withdrawn
- 2000-12-11 WO PCT/GB2000/004752 patent/WO2001044250A1/en active IP Right Grant

Also Published As

Publication number	Publication date
JP2003516994A (en)	2003-05-20
EP1242423A1 (en)	2002-09-25
WO2001044250A1 (en)	2001-06-21
US7144887B2 (en)	2006-12-05
US20030125333A1 (en)	2003-07-03
AU780554B2 (en)	2005-03-24
AU2195401A (en)	2001-06-25
CA2392955A1 (en)	2001-06-21

Publication	Publication Date	Title
GB9911863D0 (en)	1999-07-21	Therapeutic agents
GB9905010D0 (en)	1999-04-28	Therapeutic agents
GB9820113D0 (en)	1998-11-11	Therapeutic agents
IL150030A0 (en)	2002-12-01	Therapeutic agents
GB9904786D0 (en)	1999-04-28	Therapeutic agents
GB9929685D0 (en)	2000-02-09	Therapeutic agents
GB9929687D0 (en)	2000-02-09	Therapeutic agents
GB9921351D0 (en)	1999-11-10	Therapeutic agents
GB9911881D0 (en)	1999-07-21	Therapeutic agents
GB9903476D0 (en)	1999-04-07	Therapeutic agents
PL339848A1 (en)	2000-10-23	Therapeutic agent against hypephosphataemia
GB9801210D0 (en)	1998-03-18	Therapeutic agents
AP9901436A0 (en)	1999-03-31	Therapeutic agents
GB9929569D0 (en)	2000-02-09	Therapeutic agents
GB9911802D0 (en)	1999-07-21	Therapeutic combination
GB9911803D0 (en)	1999-07-21	Therapeutic combination
GB9914745D0 (en)	1999-08-25	Therapeutic agents
GB9914744D0 (en)	1999-08-25	Therapeutic agents
GB9911804D0 (en)	1999-07-21	Therapeutic combination
GB9801202D0 (en)	1998-03-18	Therapeutic agents
GB9903119D0 (en)	1999-04-07	Therapeutic agents
GB9914742D0 (en)	1999-08-25	Therapeutic agents
GB9902881D0 (en)	1999-03-31	Therapeutic agents
GB9914743D0 (en)	1999-08-25	Therapeutic agents
GB9911238D0 (en)	1999-07-14	Therapeutic use

Legal Events

Date	Code	Title	Description
2001-03-14	AT	Applications terminated before publication under section 16(1)